CAS No.
[80-08-0 unlabeled]
Storage Condition
Refer MSDS for complete information
Synonyms
4,4′-Sulfonylbisbenzamine-13C12
Application Notes
Useful research chemical for a range of applications
Hazard Compound
Refer MSDS for complete information
Dapsone 13C12 is a drug product that is used as an analytical standard for HPLC, as well as in research and development of drugs.
Refund Policy
We are committed to offering products of the highest quality in order to meet the needs of our customers, and have elaborate systems in
place to ensure that material specifications, their certification and all handling and storage conditions are communicated at the time of
material handover.
We have invested in the highest quality packaging materials and use international logistics partners to service our customers. While all
possible precautions have been taken to deliver the required product(s), there may be some rare situations when our product does not
meet your requirements. Should that arise, please contact us with your concerns and we will endeavour to address them on a priority
basis. If there is no other option, we will either replace your product(s) or issue a refund or account credit, whichever you prefer.
If there is an issue with one or more of our products, our policy is that it must be reported to us within 45 days of your receiving shipment.
While we will always address product issues after the 45 day return window has passed, we cannot issue a refund or account credit. As
always, we appreciate your support.
Dapsone 13C12 usage and description
[13C12]-Dapsone is a stable isotope-labeled form of the drug Dapsone, which is commonly used in the treatment of leprosy and certain skin conditions such as dermatitis herpetiformis. Dapsone works by inhibiting the growth of bacteria and reducing inflammation in the affected areas. The addition of thirteen carbon atoms to the molecular structure of Dapsone in [13C12]-Dapsone allows for more precise tracking and analysis of the drug's metabolism and distribution within the body.
[13C12]-Dapsone is commonly used in clinical studies to investigate the pharmacokinetics and pharmacodynamics of Dapsone in different populations, such as patients with impaired liver or kidney function. It is also used in drug interaction studies to determine the effects of other drugs on the metabolism of Dapsone. The use of stable isotope-labeled drugs like [13C12]-Dapsone provides valuable information on drug safety and efficacy, which can ultimately lead to the development of improved treatment options for patients.
Chemically, [13C12]-Dapsone has a molecular weight of 295.3 g/mol and a chemical formula of C12H8D13ClN4O2S. It is available both as a powder and in solution form. The drug is typically administered orally, with dosages varying depending on the condition being treated and the patient's individual needs. Adverse reactions to Dapsone, including [13C12]-Dapsone, can include nausea, vomiting, headache, and dizziness. It is important for patients to discuss any potential risks and benefits of using Dapsone with their healthcare provider before beginning treatment.
